Teleflex Incorporated (NYSE:TFX) Director Sells $2,929,082.97 in Stock

Teleflex Incorporated (NYSE:TFX) Director Benson Smith sold 8,481 shares of Teleflex stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $345.37, for a total transaction of $2,929,082.97. Following the sale, the director now owns 57,290 shares in the company, valued at approximately $19,786,247.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Benson Smith also recently made the following trade(s):

  • On Thursday, October 31st, Benson Smith sold 17,000 shares of Teleflex stock. The shares were sold at an average price of $340.01, for a total transaction of $5,780,170.00.
  • On Monday, September 23rd, Benson Smith sold 8,500 shares of Teleflex stock. The stock was sold at an average price of $340.00, for a total transaction of $2,890,000.00.

Shares of NYSE:TFX opened at $331.18 on Friday. The company has a current ratio of 2.33, a quick ratio of 1.44 and a debt-to-equity ratio of 0.72. The company has a fifty day simple moving average of $331.86 and a 200 day simple moving average of $328.98. The firm has a market cap of $15.57 billion, a PE ratio of 33.45, a price-to-earnings-growth ratio of 2.12 and a beta of 0.96. Teleflex Incorporated has a 12-month low of $226.02 and a 12-month high of $373.90.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, October 31st. The medical technology company reported $2.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.75 by $0.22. The business had revenue of $648.32 million during the quarter, compared to analyst estimates of $643.20 million. Teleflex had a net margin of 17.36% and a return on equity of 18.81%. The business’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.52 earnings per share. As a group, equities research analysts forecast that Teleflex Incorporated will post 11.08 EPS for the current fiscal year.

The firm also recently disclosed a dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be issued a $0.34 dividend. The ex-dividend date is Thursday, November 14th. Teleflex’s dividend payout ratio is presently 13.74%.

A number of analysts recently issued reports on TFX shares. Leerink Swann set a $405.00 price target on shares of Teleflex and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Morgan Stanley lifted their price target on shares of Teleflex from $345.00 to $392.00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. Needham & Company LLC set a $403.00 price target on shares of Teleflex and gave the stock a “buy” rating in a research note on Tuesday, October 15th. Svb Leerink lifted their price target on shares of Teleflex from $395.00 to $405.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 4th. Finally, Barclays set a $365.00 price target on shares of Teleflex and gave the stock a “hold” rating in a research note on Friday, November 1st. Three investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $381.30.

A number of institutional investors have recently added to or reduced their stakes in the business. Neuburgh Advisers LLC boosted its holdings in Teleflex by 3.0% in the second quarter. Neuburgh Advisers LLC now owns 1,088 shares of the medical technology company’s stock worth $360,000 after purchasing an additional 32 shares during the period. NEXT Financial Group Inc boosted its holdings in Teleflex by 13.7% in the second quarter. NEXT Financial Group Inc now owns 274 shares of the medical technology company’s stock worth $91,000 after purchasing an additional 33 shares during the period. HM Payson & Co. boosted its holdings in Teleflex by 0.3% in the second quarter. HM Payson & Co. now owns 12,706 shares of the medical technology company’s stock worth $4,208,000 after purchasing an additional 37 shares during the period. Keybank National Association OH boosted its holdings in Teleflex by 1.6% in the third quarter. Keybank National Association OH now owns 2,481 shares of the medical technology company’s stock worth $843,000 after purchasing an additional 38 shares during the period. Finally, Hartford Investment Management Co. boosted its holdings in Teleflex by 0.9% in the second quarter. Hartford Investment Management Co. now owns 5,081 shares of the medical technology company’s stock worth $1,683,000 after purchasing an additional 44 shares during the period. 90.63% of the stock is owned by hedge funds and other institutional investors.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

See Also: What is a balanced fund?

Insider Buying and Selling by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.